ARQT - Arcutis Biotherapeutics Inc. (ARQT) Q1 2024 Earnings Call Transcript
2024-05-14 19:47:10 ET
Arcutis Biotherapeutics, Inc. (ARQT)
Q1 2024 Earnings Conference Call
May 14, 2024, 4:30 PM ET
Company Participants
Latha Vairavan - Vice President, Finance and Head of Investor Relations
Frank Watanabe - President and Chief Executive Officer
Todd Edwards - Chief Commercial Officer
Patrick Burnett - Chief Medical Officer
David Topper - Chief Financial Officer
Conference Call Participants
Serge Belanger - Needham
Seamus Fernandez - Guggenheim Securities
Vikram Purohit - Morgan Stanley
Tyler Van Buren - TD Cowen
Uy Ear - Mizuho Securities
Presentation
Operator
Good day and welcome to Arcutis Biotherapeutics' 2024 First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to Latha Vairavan, Vice President, Finance and Investor Relations. Please go ahead.
Latha Vairavan
Thank you. Good afternoon, everyone, and thank you for joining us today to review our first quarter 2024 financial results and business update. Slides for today's call are available on the Investors section of the Arcutis website.
On the call today are Frank Watanabe, President and CEO; Patrick Burnett, Chief Medical Officer; Todd Edwards, Chief Commercial Officer; and David Topper, Chief Financial Officer.
I'd remind everyone that we will be making forward-looking statements during this call. These statements are subject to certain risks and uncertainties and our actual results may differ. We encourage you to review all of the company's filings with the Securities and Exchange Commission, including descriptions of our business and risk factors....
Arcutis Biotherapeutics, Inc. (ARQT) Q1 2024 Earnings Call Transcript